CIK 0001781983 · Non-accelerated filer<br>Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 52 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-28 | Grissinger Michael Director | Grant or award · Stock Option (right to Buy) | +29,575 | 29,575 | ||
| 2022-07-28 | Gilad Oren President, CEO | Grant or award | +101,300 | 330,314 | ||
| 2022-07-28 | Gilad Oren President, CEO | Grant or award · Stock Option (right to Buy) | +148,700 | 148,700 | ||
| 2022-07-28 | Duey Marc Director | Grant or award | +5,995 | 157,899 | ||
| 2022-07-28 | Duey Marc Director | Grant or award · Stock Option (right to Buy) | +29,575 | 29,575 | ||
| 2022-07-28 | Coiante Scott M SVP, Chief Financial Officer | Grant or award | +60,800 | 145,065 | ||
| 2022-07-28 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (right to Buy) | +89,200 | 89,200 | ||
| 2022-06-03 | SCHADE CHRISTIAN S Chairman & CEO | Shares withheld for taxes | −65,770 | $0.81 | $53K | 226,846 |
| 2022-06-03 | Coiante Scott M SVP, Chief Financial Officer | Shares withheld for taxes | −35,284 | $0.81 | $28K | 84,265 |
| 2022-06-03 | Korbel Gregory Alan SVP, Chief Operating Officer | Shares withheld for taxes | −8,390 | $0.81 | $7K | 21,462 |
| 2022-06-03 | Attar Eyal C. SVP, Chief Medical Officer | Shares withheld for taxes | −32,667 | $0.81 | $26K | 57,233 |
| 2022-05-18 | Seizinger Bernd R. Director | Purchase | +50,000 | $0.71 | $36K | 318,580 |
| 2022-05-18 | SCHADE CHRISTIAN S Chairman & CEO | Purchase | +37,500 | $0.64 | $24K | 292,616 |
| 2022-03-10 | SCHADE CHRISTIAN S Chairman & CEO | Grant or award | +100,100 | 255,116 | ||
| 2022-03-10 | SCHADE CHRISTIAN S Chairman & CEO | Grant or award · Stock Option (right to Buy) | +427,700 | 427,700 | ||
| 2022-03-10 | Korbel Gregory Alan SVP, Chief Business Officer | Grant or award | +16,000 | 31,841 | ||
| 2022-03-10 | Korbel Gregory Alan SVP, Chief Business Officer | Shares withheld for taxes | −1,989 | $1.82 | $4K | 29,852 |
| 2022-03-10 | Korbel Gregory Alan SVP, Chief Business Officer | Grant or award · Stock Option (right to Buy) | +72,600 | 72,600 | ||
| 2022-03-10 | Coiante Scott M SVP, Chief Financial Officer | Grant or award | +42,900 | 119,549 | ||
| 2022-03-10 | Coiante Scott M SVP, Chief Financial Officer | Grant or award · Stock Option (right to Buy) | +185,900 | 185,900 |
Page 8 of 10 · 197 trades